Crossref
Efficacy and Safety of Linezolid in the Treatment of Nontuberculous Mycobacterial Pulmonary Disease: A Review
Drug Targets and Therapeutics · 2023
DOI: 10.58502/dtt.23.0017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Targets and Therapeutics, 2023. Verfasst von Mi Seon Park und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Park, M. S., & Choi, E. J. (2023). Efficacy and Safety of Linezolid in the Treatment of Nontuberculous Mycobacterial Pulmonary Disease: A Review. Drug Targets and Therapeutics. https://doi.org/10.58502/dtt.23.0017
Vancouver
Park MS, Choi EJ. Efficacy and Safety of Linezolid in the Treatment of Nontuberculous Mycobacterial Pulmonary Disease: A Review. Drug Targets and Therapeutics. 2023. doi:10.58502/dtt.23.0017
BibTeX
@article{Park2023,
author = {Park, Mi Seon and Choi, Eun Joo},
title = {Efficacy and Safety of Linezolid in the Treatment of Nontuberculous Mycobacterial Pulmonary Disease: A Review},
journal = {Drug Targets and Therapeutics},
year = {2023},
doi = {10.58502/dtt.23.0017}
}
EUVIMED